Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Early Success For 4D Pharma’s Microbiome Plus Keytruda Combination

Micro-Cap Stock Rises

Aug 27 2020

• By Andrew McConaghie

Bacteria — 4D Pharma's 'live biotherapeutic' aims to activate a patient's immune system and enable a response to checkpoint inhibitor Keytruda

Related Content

Ferring Hails World First Positive Phase III Data For Microbiome Product

May 07 2020

Related Companies

Ferring Pharmaceuticals

Merck & Co., Inc.

Seres Therapeutics, Inc.

Additional Topics

Clinical Trials Commercial Companies StartUps and SMEs BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.